CLS Holdings USA, Inc. (CLSH)
OTCMKTS · Delayed Price · Currency is USD
0.0361
0.00 (0.00%)
Aug 3, 2025, 8:00 PM EDT
CLS Holdings USA Market Cap
CLS Holdings USA has a market cap or net worth of $6.05 million as of August 5, 2025. Its market cap has decreased by -20.14% in one year.
Market Cap
6.05M
Enterprise Value
9.53M
Revenue
17.54M
Ranking
n/a
PE Ratio
13.14
Stock Price
$0.04
Market Cap Chart
Since June 23, 2015, CLS Holdings USA's market cap has decreased from 15.19M to 6.05M, a decrease of -60.19%. That is a compound annual growth rate of -8.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 6.05M | 20.35% |
| Dec 31, 2024 | 5.02M | 62.97% |
| Dec 29, 2023 | 3.08M | -43.35% |
| Dec 30, 2022 | 5.44M | -55.95% |
| Dec 31, 2021 | 12.35M | -34.05% |
| Dec 31, 2020 | 18.73M | -32.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 519.96M |
| Glass House Brands | 438.99M |
| American Oncology Network | 408.39M |
| Northwest Biotherapeutics | 376.73M |
| CytoDyn | 366.82M |